ATH vs EYE

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ATH

ALTERITY FPO [ATH]

58MEDIUM

EYE

NOVA EYE FPO [EYE]

58MEDIUM

Score Breakdown

ATH EYE
Technical
56
46
Catalyst
56
54
Sentiment
50
50
Fundamental
44
60
Momentum
49
65
Risk Gate
50
50

Key Metrics

ATH Metric EYE
$111.4MMarket Cap$38.5M
408KAvg Volume (20d)199K
+0.1%Short InterestN/A
$0.78552-Week High$0.205
$0.35052-Week Low$0.100
-2.9%Daily Change+3.8%
$0.505Reference Price$0.135
-55.0%ROE-26.1%
N/AProfit Margin-12.4%

Active Signals

ATH Signals

●Trading below both moving averages — the trend is working against this one
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (7 quarters)
●Revenue in sharp decline (-61%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised downward (-10pts)
●CANSLIM I: Institutional ownership (19%)

EYE Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (1.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

Ask Scout AI to compare ATH and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AHC vs ARX →AHC vs ATX →AHC vs BLS →AHC vs IIQ →AHC vs LDX →
ATH Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).